Immunic, Inc. shares fall 1.43% after-hours as ImmunoPrecise Antibodies Ltd. reports earnings miss and auditor raises 'going concern' doubt.

Immunic, Inc. declined 1.43% in after-hours trading. The company's stock price movement may be influenced by the recent news events related to ImmunoPrecise Antibodies Ltd., which reported earnings results for the fourth quarter and full year ended April 30, 2025, and had its auditor raise a 'going concern' doubt. Additionally, ImmunoPrecise Antibodies Ltd. divested its Netherlands facilities to AVS Bio, which may have impacted investor sentiment.